ATE141283T1 - Verfahren zur reinigung eines hochglykosylierten proteins - Google Patents

Verfahren zur reinigung eines hochglykosylierten proteins

Info

Publication number
ATE141283T1
ATE141283T1 AT92400381T AT92400381T ATE141283T1 AT E141283 T1 ATE141283 T1 AT E141283T1 AT 92400381 T AT92400381 T AT 92400381T AT 92400381 T AT92400381 T AT 92400381T AT E141283 T1 ATE141283 T1 AT E141283T1
Authority
AT
Austria
Prior art keywords
purifying
highly glycosylated
glycosylated protein
protein
mixture
Prior art date
Application number
AT92400381T
Other languages
English (en)
Inventor
Hanno Kolbe
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE141283T1 publication Critical patent/ATE141283T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification
    • Y10S435/816Enzyme separation or purification by solubility

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92400381T 1991-02-15 1992-02-13 Verfahren zur reinigung eines hochglykosylierten proteins ATE141283T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9101830A FR2672895B1 (fr) 1991-02-15 1991-02-15 Procede de purification d'une proteine fortement glycosylee.

Publications (1)

Publication Number Publication Date
ATE141283T1 true ATE141283T1 (de) 1996-08-15

Family

ID=9409766

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92400381T ATE141283T1 (de) 1991-02-15 1992-02-13 Verfahren zur reinigung eines hochglykosylierten proteins

Country Status (9)

Country Link
US (1) US5276141A (de)
EP (1) EP0499541B1 (de)
JP (1) JP3376430B2 (de)
AT (1) ATE141283T1 (de)
CA (1) CA2061167C (de)
DE (1) DE69212660T2 (de)
DK (1) DK0499541T3 (de)
ES (1) ES2092067T3 (de)
FR (1) FR2672895B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5760189A (en) * 1995-06-02 1998-06-02 Genetics Institute, Inc. Protein recovery & purification methods
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
EP1189935B1 (de) * 1999-06-25 2008-10-22 Wyeth Holdings Corporation Extraktion von integralen membranproteinen
AU1198701A (en) * 1999-10-13 2001-04-23 Lexicon Genetics Incorporated Novel human membrane proteins
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
CA2548378A1 (en) * 2003-12-30 2005-07-14 Bharat Biotech International Limited A process for the preparation and purification of recombinant proteins
BRPI0810951B8 (pt) * 2007-05-29 2021-05-25 Beijing Wantai Biological Pharmacy Entpr Co Ltd proteína l1 do hpv6, polinucleotídeo, vetor, célula, partícula semelhante ao vírus (vlp) hpv6, método para produzir a proteína hpv6 l1 truncada, vacina para prevenção de condiloma acuminado ou de infecções por hpv, uso da proteína hpv6 l1 truncada, método para prevenção de condiloma acuminado ou infecções por hpv, método para obter uma vlp de uma proteína l1 do hpv6 e método para produzir uma vacina para a prevenção de condiloma acuminado ou de infecções por hpv
US20160130324A1 (en) 2014-10-31 2016-05-12 Shire Human Genetic Therapies, Inc. C1 Inhibitor Fusion Proteins and Uses Thereof
MA43270A (fr) 2015-11-19 2021-06-02 Takeda Pharmaceuticals Co Inhibiteur de la c1 estérase humaine recombinante et ses utilisations
US20220056481A1 (en) * 2018-12-28 2022-02-24 Transgene M2-defective poxvirus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947324A (en) * 1975-04-21 1976-03-30 G. D. Searle And Co. Method for isolating high purity peroxidase
JPS6098988A (ja) * 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Lpf−haの精製法
EP0213099A3 (de) * 1985-08-23 1989-07-19 Cederroth Nordic Aktiebolag Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
US4798886A (en) * 1986-03-24 1989-01-17 Takeda Chemical Industries, Ltd. Mutual separation of proteins
FR2597344B1 (fr) * 1986-04-16 1989-06-23 Merieux Inst Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire.
IL85255A0 (en) * 1987-01-30 1988-07-31 Int Minerals & Chem Corp Recovery of somatotropin from dilute aqueous solutions
EP0321606B1 (de) * 1987-12-23 1993-09-29 IMMUNO Aktiengesellschaft Zelluläre amphipatische Proteine in aggregierten Formen und Verfahren zur Herstellung und Reinigung diese Proteine
US4992372A (en) * 1989-02-02 1991-02-12 Pokora Alexander R Method for removing impurities from peroxidase solutions
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis

Also Published As

Publication number Publication date
DK0499541T3 (da) 1996-12-02
CA2061167A1 (fr) 1992-08-16
JPH04312600A (ja) 1992-11-04
DE69212660D1 (de) 1996-09-19
US5276141A (en) 1994-01-04
FR2672895B1 (fr) 1995-05-12
EP0499541A1 (de) 1992-08-19
FR2672895A1 (fr) 1992-08-21
EP0499541B1 (de) 1996-08-14
ES2092067T3 (es) 1996-11-16
DE69212660T2 (de) 1997-03-13
JP3376430B2 (ja) 2003-02-10
CA2061167C (fr) 2002-06-11

Similar Documents

Publication Publication Date Title
BR9407047A (pt) Processo para separaçao de uma proteina de uma soluçao aquosa de proteinas
ATE141283T1 (de) Verfahren zur reinigung eines hochglykosylierten proteins
DE69631996D1 (de) Verfahren zur Herstellung von acylierten Proteinpuder
DE69833779D1 (de) Verfahren und zusammensetzungen zur immunomodulation
DE3856362D1 (de) Regelung von elektrostatischen interaktionen an metallionen-bindungsstellen zur stabilisierung von proteinen
ATE352617T1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
DE3877834D1 (de) Verfahren zur behandlung von abgasen.
DK1175909T3 (da) Terapeutiske sammensætninger af antistoffer og antisense-nukleinsyrer mod Serrate
DE3382413D1 (de) Verfahren zur herstellung eines adhaesionsbindemittels aus protein.
DE59008334D1 (de) Verfahren zur Präparierung von biologischem Implantationsmaterial.
DE69626980D1 (de) Inhibinzusammensetzungen und verfahren zur erhöhung der reproduzierenden leistung
NZ512942A (en) Polynucleotides encoding the IL-13 binding chains of the interleukin receptor, pharmaceutical compositions comprising the protein and methods of identifying inhibitors
DE3872289D1 (de) Verfahren zur rueckgewinnung von gallium durch chelatharz.
DE3873094D1 (de) Verfahren zur aufbereitung von gas.
DE3585084D1 (de) Verfahren zur reinigung eines proteins.
ATE288482T1 (de) Verfahren zur trennung milchgerinnender enzyme
ATE353563T1 (de) Verfahren zur reinigung von hitze-schock peptidkomplexen
DE69530570D1 (de) Verfahren zur behandlung von stoehrungen des menschlichen oder tierischen koerpers durch verabreichung von aminosaeuren
DE68908438D1 (de) Zusammensetzungen und verfahren zur korrosionsinhibierung.
ATE185487T1 (de) Verfahren zur hemmung der viralen morphogenese
NO963572L (no) Inhibin-sammensetninger og fremgangsmåter for bruk av disse
DE58901662D1 (de) Verfahren zur formgebung von naturleder.
ATE529515T1 (de) Verfahren zur herstellung eines peptids mit einem pi grösser als 8 oder kleiner als 5
DE58904843D1 (de) Verfahren zur entfernung von ethanol aus durch vergaerung erzeugten getraenken.
DE3782962D1 (de) Cysteinreiche, gamma-glutaminsaeure und beta-alanin-einheiten aufweisende peptide, verfahren zu deren herstellung und ihre verwendung.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee